Guggenheim began coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a research note released on Thursday morning, Briefing.com Automated Import reports. The brokerage issued a neutral rating and a $59.00 price target on the pharmacy operator’s stock.
A number of other analysts have also recently weighed in on WBA. Zacks Investment Research raised Walgreens Boots Alliance from a sell rating to a hold rating in a research report on Friday, March 29th. BidaskClub cut Walgreens Boots Alliance from a sell rating to a strong sell rating in a research report on Saturday, April 13th. TheStreet cut Walgreens Boots Alliance from a b- rating to a c+ rating in a research report on Friday, March 29th. Pivotal Research reduced their price target on Walgreens Boots Alliance from $70.00 to $60.00 and set a hold rating for the company in a research report on Wednesday, April 3rd. Finally, Mizuho set a $67.00 price target on Walgreens Boots Alliance and gave the stock a hold rating in a research report on Thursday, March 28th. Five investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have assigned a buy rating to the stock. Walgreens Boots Alliance has an average rating of Hold and an average target price of $68.00.
Shares of NASDAQ:WBA opened at $54.63 on Thursday. Walgreens Boots Alliance has a fifty-two week low of $53.32 and a fifty-two week high of $86.31. The stock has a market capitalization of $49.95 billion, a price-to-earnings ratio of 9.07, a P/E/G ratio of 1.11 and a beta of 0.86. The company has a quick ratio of 0.38, a current ratio of 0.78 and a debt-to-equity ratio of 0.50.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share for the quarter, missing analysts’ consensus estimates of $1.70 by ($0.06). Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The company had revenue of $34.53 billion during the quarter, compared to analyst estimates of $34.57 billion. During the same period in the prior year, the firm earned $1.73 EPS. Walgreens Boots Alliance’s quarterly revenue was up 4.6% on a year-over-year basis. As a group, analysts predict that Walgreens Boots Alliance will post 5.99 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Monday, May 20th will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, May 17th. This represents a $1.76 annualized dividend and a dividend yield of 3.22%. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.
In other Walgreens Boots Alliance news, COO Ornella Barra acquired 18,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was acquired at an average price of $54.56 per share, with a total value of $982,080.00. Following the transaction, the chief operating officer now owns 26,425 shares of the company’s stock, valued at $1,441,748. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 15.73% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of WBA. Massey Quick Simon & CO. LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at about $27,000. Murphy Pohlad Asset Management LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at about $29,000. Cornerstone Advisors Inc. increased its stake in Walgreens Boots Alliance by 102.4% during the third quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 214 shares during the period. PRW Wealth Management LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at about $34,000. Finally, Nalls Sherbakoff Group LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at about $42,000. 65.05% of the stock is owned by institutional investors and hedge funds.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: What are Bollinger Bands?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.